M. López-Brea

2.5k total citations
42 papers, 1.7k citations indexed

About

M. López-Brea is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, M. López-Brea has authored 42 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Surgery, 18 papers in Pulmonary and Respiratory Medicine and 18 papers in Oncology. Recurrent topics in M. López-Brea's work include Lung Cancer Treatments and Mutations (11 papers), Lung Cancer Research Studies (7 papers) and Testicular diseases and treatments (6 papers). M. López-Brea is often cited by papers focused on Lung Cancer Treatments and Mutations (11 papers), Lung Cancer Research Studies (7 papers) and Testicular diseases and treatments (6 papers). M. López-Brea collaborates with scholars based in Spain, United Kingdom and United States. M. López-Brea's co-authors include M. E. Vega-Villegas, Fernando Rivera, Fernando Rivera, H. Cortés-Funes, P. Lianes, D. Domingo, Tomás Alarcón, Dolores Isla, R. Bastús and Miquel Tarón and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Clinical Cancer Research.

In The Last Decade

M. López-Brea

41 papers receiving 1.7k citations

Peers

M. López-Brea

ONCOL

SURGE

PRM

IMMUN

Young‐Ha Oh South Korea

Rainer Kraft Switzerland

H. Poliwoda Germany

Hui‐Hwa Tseng Taiwan

Toshio Kubo Japan

Chang Suk Kang South Korea

Geneviève Belleannée France

Murli Krishna United States

Vito Rodolico Italy

Pincas Bitterman United States

Young‐Ha Oh South Korea

M. López-Brea

627 ×0.8

ONCOL

463 ×0.7

SURGE

614 ×1.1

363 ×0.7

PRM

114 ×0.5

IMMUN

Citations per year, relative to M. López-Brea M. López-Brea (= 1×) peers Young‐Ha Oh

Countries citing papers authored by M. López-Brea

Since Specialization

Citations

This map shows the geographic impact of M. López-Brea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. López-Brea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. López-Brea more than expected).

Fields of papers citing papers by M. López-Brea

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. López-Brea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. López-Brea. The network helps show where M. López-Brea may publish in the future.

Co-authorship network of co-authors of M. López-Brea

This figure shows the co-authorship network connecting the top 25 collaborators of M. López-Brea. A scholar is included among the top collaborators of M. López-Brea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. López-Brea. M. López-Brea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Baños, J.L. Gutiérrez, et al.. (2023). Neoadjuvant chemotherapy with dose-dense MVAC in muscle-invasive bladder cancer: a tertiary center experience. Clinical & Translational Oncology. 26(2). 549–553. 3 indexed citations

Garrido, Pilar, Luis Paz‐Ares, Margarita Majem, et al.. (2021). LungBEAM: A prospective multicenter study to monitor stage IV NSCLC patients with EGFR mutations using BEAMing technology. Cancer Medicine. 10(17). 5878–5888. 14 indexed citations

Hollebecque, Antoine, Johann S. de Bono, Stefania Salvagni, et al.. (2020). 18O CC-90011 in patients (Pts) with advanced solid tumors (STs) and relapsed/refractory non-Hodgkin lymphoma (R/R NHL): Updated results of a phase I study. Annals of Oncology. 31. S6–S6. 3 indexed citations

González‐Billalabeitia, Enrique, Juan Manuel Sepúlveda-Sánchez, Pablo Maroto, et al.. (2016). Consensus Recommendations from the Spanish Germ Cell Cancer Group on the Use of High-dose Chemotherapy in Germ Cell Cancer. European Urology Focus. 3(2-3). 280–286. 3 indexed citations

Viñolas, Núria, Mariano Provencio, Noemı́ Reguart, et al.. (2010). Single nucleotide polymorphisms in MDR1 gen correlates with outcome in advanced non-small-cell lung cancer patients treated with cisplatin plus vinorelbine. Lung Cancer. 71(2). 191–198. 39 indexed citations

Rivera, Fernando, M. E. Vega-Villegas, & M. López-Brea. (2008). Cetuximab, its clinical use and future perspectives. Anti-Cancer Drugs. 19(2). 99–113. 49 indexed citations

López-Brea, M., Tomás Alarcón, D. Domingo, & Jazmín Díaz-Regañón. (2007). Inhibitory effect of Gram-negative and Gram-positive microorganisms against Helicobacter pylori clinical isolates. Journal of Antimicrobial Chemotherapy. 61(1). 139–142. 21 indexed citations

Rivera, Fernando, M. E. Vega-Villegas, M. López-Brea, et al.. (2007). Randomized phase II study of cisplatin and 5-FU continuous infusion (PF) versus cisplatin, UFT and vinorelbine (UFTVP) as induction chemotherapy in locally advanced squamous cell head and neck cancer (LA-SCHNC). Cancer Chemotherapy and Pharmacology. 62(2). 253–261. 8 indexed citations

Rivera, Fernando, et al.. (2007). Current situation of Panitumumab, Matuzumab, Nimotuzumab and Zalutumumab. Acta Oncologica. 47(1). 9–19. 66 indexed citations

10.

Dómine, Manuel, Mariano Provencio, Christian Rolfo, et al.. (2007). P3-080: Erlotinib as single agent in men with advanced or metastatic NSCLC: A retrospective analysis. Journal of Thoracic Oncology. 2(8). S712–S713. 2 indexed citations

11.

Rivera, Fernando, M. E. Vega-Villegas, & M. López-Brea. (2007). Chemotherapy of advanced gastric cancer. Cancer Treatment Reviews. 33(4). 315–324. 115 indexed citations

12.

Aparicio, Jorge, J.R. Germà, Xavier García del Muro, et al.. (2005). Risk-Adapted Management for Patients With Clinical Stage I Seminoma: The Second Spanish Germ Cell Cancer Cooperative Group Study. Journal of Clinical Oncology. 23(34). 8717–8723. 134 indexed citations

13.

Gómez‐Román, Javier, Pilar Sáenz, Simon Santa Cruz, et al.. (2005). Fibroblast Growth Factor Receptor 3 Is Overexpressed in Urinary Tract Carcinomas and Modulates the Neoplastic Cell Growth. Clinical Cancer Research. 11(2). 459–465. 100 indexed citations

14.

Isla, Dolores, Carme Sarries, Rafael Rosell, et al.. (2004). Single nucleotide polymorphisms and outcome in docetaxel–cisplatin-treated advanced non-small-cell lung cancer. Annals of Oncology. 15(8). 1194–1203. 255 indexed citations

15.

Nan, Daniel, et al.. (2003). Diabetes Mellitus Following Cisplatin Treatment. Acta Oncologica. 42(1). 75–78. 20 indexed citations

16.

García‐Carbonero, Rocio, José Mayordomo, M. López-Brea, et al.. (2001). Granulocyte Colony-Stimulating Factor in the Treatment of High-Risk Febrile Neutropenia: a Multicenter Randomized Trial. JNCI Journal of the National Cancer Institute. 93(1). 31–38. 121 indexed citations

17.

Alarcón, Tomás, D. Domingo, N. Prieto, & M. López-Brea. (2000). Clarithromycin resistance stability in Helicobacter pylori: influence of the MIC and type of mutation in the 23S rRNA. Journal of Antimicrobial Chemotherapy. 46(4). 613–616. 31 indexed citations

18.

Hidalgo, Manuel, Luis Paz‐Ares, Fernando Rivera, et al.. (1997). Mediastinal non-seminomatous germ cell tumours (MNSGCT) treated with cisplatin-based combination chemotherapy. Annals of Oncology. 8(6). 555–559. 23 indexed citations

19.

Otero, María José, et al.. (1996). Scedosporium apiospermum pneumonia after autologous bone marrow transplantation. European Journal of Clinical Microbiology & Infectious Diseases. 15(7). 600–603. 21 indexed citations

20.

Mayordomo, José, Luis Paz‐Ares, Fernando Rivera, et al.. (1994). Ovarian and extragonadal malignant germ-cell tumors in females: A single-institution experience with 43 patients. Annals of Oncology. 5(3). 225–231. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact